Evercore ISI analyst Elizabeth Anderson lowered the firm’s price target on Dentsply Sirona (XRAY) to $13 from $17 and keeps an In Line rating on the shares as the firm updates estimates and makes several tactical calls in the Healthcare Technology & Distribution group ahead of Q3 earnings season.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- DENTSPLY SIRONA Announces Leadership Transition for Rosenzweig
- Dentsply Sirona appoints Denti as Chief Commercial Officer
- Cautious Hold Rating on DENTSPLY SIRONA Amid Awaited Turnaround Evidence
- DENTSPLY SIRONA Approves Retention Award for Executives
- Hold Rating for DENTSPLY SIRONA Amid Strategic Retention of Wellspect and Focus on Core Dental Business Revitalization